메테나민(Methenamine) 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측, 용도별, 판매채널별, 지역별, 경쟁별(2020-2035년)

The global Methenamine market was valued at 502.72 thousand tonnes in 2024 and is projected to reach 740.94 thousand tonnes by 2035, registering a Compound Annual Growth Rate (CAGR) of 3.59% over the forecast period.

The global Methenamine market is dynamic and driven by its broad range of applications across various industries. Methenamine, also known as hexamethylenetetramine, is widely used in pharmaceuticals, plastics, and as a disinfectant. In the pharmaceutical sector, it plays a critical role in treating urinary tract infections (UTIs), offering antimicrobial properties that combat specific bacterial strains. According to a World Health Organization (WHO) report, the growing resistance to common antibiotics in bacterial infections is contributing to increased demand. Over 60% of Neisseria gonorrhoeae isolates, a major cause of sexually transmitted infections, have shown resistance to ciprofloxacin, a widely used antibiotic. Additionally, more than 20% of E. coli isolates, a leading cause of UTIs, demonstrate resistance to both first-line (ampicillin, co-trimoxazole) and second-line (fluoroquinolones) treatments.

Key Market Drivers

Growing Demand for Methenamine in Pharmaceutical Applications

One of the main drivers of the global Methenamine market is its increasing use in the pharmaceutical industry, especially for its antimicrobial properties in treating UTIs. As UTIs remain one of the most common bacterial infections worldwide, the rising prevalence of these infections, particularly among women and the elderly, is fueling demand for Methenamine-based treatments. Methenamine is highly effective at preventing bacterial growth in the urinary tract and is frequently prescribed in combination with other drugs to enhance its therapeutic effects. In September 2024, Mankind Pharma Ltd. introduced its RAPID NEWS self-test kits to address prevalent health concerns such as UTIs, dengue, and early menopause. This innovation aims to make healthcare more accessible by offering individuals across India a convenient, private, and rapid testing solution.

Key Market Challenges

Regulatory Hurdles and Compliance Issues

The global Methenamine market faces significant regulatory challenges, which may hinder its growth. Methenamine, due to its classification as a chemical compound with multiple industrial applications, is subject to stringent regulations across different countries. These regulations primarily focus on safety standards, environmental impact, and potential risks to human health. Governments in regions such as the European Union, North America, and Asia Pacific have imposed limits on the manufacturing and use of chemicals like Methenamine due to concerns over their toxicity and environmental effects. Companies in this sector must navigate complex regulatory frameworks, including safety certifications, environmental approvals, and product registrations, which can delay time-to-market and increase operational costs. Additionally, the evolving nature of regulatory policies and the potential introduction of new laws add uncertainty to the market landscape.

Key Market Trends

Technological Advancements in Methenamine Production

Technological innovations in Methenamine production are driving the expansion of the global market. As demand for Methenamine grows across various industries, more efficient and cost-effective manufacturing processes are essential to meet market needs. New advancements in production technologies, such as sustainable manufacturing methods and improved reaction conditions, have significantly reduced production costs and increased output. This has made Methenamine more accessible to industries requiring large quantities of the compound.

Key Market Players

• Shandong Shengxuelong Chemical Co., Ltd.
• UCC Shchekinoazot
• Sina Chemical Industries Company
• Henan Runhua Chemicals Co., Ltd.
• Guangzhou Hanpu Pharmaceutical Co. Ltd
• Zaozhuang Xudong Chemical Technology Co., Ltd.
• Simalin Chemical Industries Private Limited

Report Scope

This report segments the Global Methenamine Market into the following categories, along with detailed insights into industry trends:

Methenamine Market by End-Use:

• Synthetic Resin
• Rubber Industry
• Textile Industry
• Other Industries

Methenamine Market by Sales Channel:

• Direct Sales
• Indirect Sales

Methenamine Market by Region:

• North America: United States, Canada, Mexico
• Europe: France, United Kingdom, Italy, Germany, Spain
• Asia-Pacific: China, India, Japan, Australia, South Korea
• South America: Brazil, Argentina, Colombia
• Middle East & Africa: South Africa, Saudi Arabia, UAE

Competitive Landscape

Company Profiles: In-depth analysis of the leading companies operating in the Global Methenamine Market.

Available Customizations:

The Global Methenamine Market report can be customized based on specific company needs. Customization options include:

• Company Information: Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Methenamine Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By End-Use (Synthetic Resin, Rubber Industry, Textile Industry, and Others)
  • 5.2.2. By Sales Channel (Direct Sale and Indirect Sale)
  • 5.2.3. By Company (2024)
  • 5.2.4. By Region
• 5.3. Market Map

6. North America Methenamine Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By End-Use
  • 6.2.2. By Sales Channel
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Methenamine Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By End-Use
      • 6.3.1.2.2. By Sales Channel
  • 6.3.2. Mexico Methenamine Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By End-Use
      • 6.3.2.2.2. By Sales Channel
  • 6.3.3. Canada Methenamine Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By End-Use
      • 6.3.3.2.2. By Sales Channel

7. Europe Methenamine Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By End-Use
  • 7.2.2. By Sales Channel
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Methenamine Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By End-Use
      • 7.3.1.2.2. By Sales Channel
  • 7.3.2. Germany Methenamine Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By End-Use
      • 7.3.2.2.2. By Sales Channel
  • 7.3.3. United Kingdom Methenamine Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By End-Use
      • 7.3.3.2.2. By Sales Channel
  • 7.3.4. Italy Methenamine Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By End-Use
      • 7.3.4.2.2. By Sales Channel
  • 7.3.5. Spain Methenamine Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By End-Use
      • 7.3.5.2.2. By Sales Channel

8. Asia-Pacific Methenamine Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By End-Use
  • 8.2.2. By Sales Channel
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Methenamine Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By End-Use
      • 8.3.1.2.2. By Sales Channel
  • 8.3.2. India Methenamine Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By End-Use
      • 8.3.2.2.2. By Sales Channel
  • 8.3.3. South Korea Methenamine Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By End-Use
      • 8.3.3.2.2. By Sales Channel
  • 8.3.4. Japan Methenamine Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By End-Use
      • 8.3.4.2.2. By Sales Channel
  • 8.3.5. Australia Methenamine Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By End-Use
      • 8.3.5.2.2. By Sales Channel

9. South America Methenamine Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By End-Use
  • 9.2.2. By Sales Channel
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Methenamine Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By End-Use
      • 9.3.1.2.2. By Sales Channel
  • 9.3.2. Argentina Methenamine Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By End-Use
      • 9.3.2.2.2. By Sales Channel
  • 9.3.3. Colombia Methenamine Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By End-Use
      • 9.3.3.2.2. By Sales Channel

10. Middle East and Africa Methenamine Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By End-Use
  • 10.2.2. By Sales Channel
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Methenamine Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By End-Use
      • 10.3.1.2.2. By Sales Channel
  • 10.3.2. Saudi Arabia Methenamine Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By End-Use
      • 10.3.2.2.2. By Sales Channel
  • 10.3.3. UAE Methenamine Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By End-Use
      • 10.3.3.2.2. By Sales Channel

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porters Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Shandong Shengxuelong Chemical Co., Ltd.
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. UCC Shchekinoazot
• 14.3. Sina Chemical Industries Company
• 14.4. Henan Runhua Chemicals Co.,Ltd
• 14.5. Guangzhou Hanpu Pharmaceutical Co Ltd
• 14.6. Zaozhuang xudong chemical technology co., ltd.
• 14.7. Simalin Chemical Industries Private Limited

15. Strategic Recommendations

16. About Us & Disclaimer